| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... MedRxiv, 2021 | 281 | 2021 |
| Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis T Wagner, FNU Shweta, K Murugadoss, S Awasthi, AJ Venkatakrishnan, ... Elife 9, e58227, 2020 | 101 | 2020 |
| Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines R McMurry, P Lenehan, S Awasthi, E Silvert, A Puranik, C Pawlowski, ... Med 2 (8), 965-978. e5, 2021 | 58 | 2021 |
| COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance MJM Niesen, P Anand, E Silvert, R Suratekar, C Pawlowski, P Ghosh, ... MedRxiv, 2021.07. 01.21259833, 2021 | 31 | 2021 |
| SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes C Pawlowski, E Silvert, JC O'Horo, PJ Lenehan, D Challener, E Gnass, ... PNAS nexus 1 (3), pgac071, 2022 | 29 | 2022 |
| Augmented curation of unstructured clinical notes from a massive EHR system reveals specific phenotypic signature of impending COVID-19 diagnosis FNU Shweta, K Murugadoss, S Awasthi, AJ Venkatakrishnan, A Puranik, ... arXiv preprint arXiv:2004.09338, 2020 | 29 | 2020 |
| Surveillance of safety of 3 doses of COVID-19 mRNA vaccination using electronic health records MJM Niesen, C Pawlowski, JC O’Horo, DW Challener, E Silvert, ... JAMA network open 5 (4), e227038-e227038, 2022 | 25 | 2022 |
| Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... Med 3 (1), 28-41. e8, 2022 | 23 | 2022 |
| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. MedRxiv Prepr. Serv A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... Health Sci 6, 2021, 2021 | 13* | 2021 |
| Female-male differences in COVID vaccine adverse events have precedence in seasonal flu shots: a potential link to sex-associated baseline gene expression patterns AJ Venkatakrishnan, P Kumar-M, E Silvert, E Garcia-Rivera, M Szenk, ... MedRxiv, 2021.04. 01.21254798, 2021 | 10 | 2021 |
| Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA vaccines for COVID-19 from Moderna and Pfizer R McMurry, P Lenehan, S Awasthi, E Silvert, A Puranik, C Pawlowski, ... BioNtech. medRxiv 20, 2021, 2021 | 7 | 2021 |
| Three doses of COVID-19 mRNA vaccination are safe based on adverse events reported in electronic health records MJM Niesen, C Pawlowski, JC O’Horo, DW Challener, E Silvert, ... medRxiv, 2021.11. 05.21265961, 2021 | 6 | 2021 |
| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. medRxiv 2021.08. 06.21261707 A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... Acesso em 18, 12, 2021 | 6 | 2021 |
| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. medRxiv [Preprint posted online August 9, 2021] A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... DOI, 0 | 6 | |
| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. August 21, 2021 (https://www. medrxiv. org/content/10. 1101 … A Puranik, PJ Lenehan, E Silvert preprint, 0 | 6 | |
| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. August 21, 2021 A Puranik, PJ Lenehan, E Silvert | 6 | |
| Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants AJ Venkatakrishnan, P Anand, PJ Lenehan, P Ghosh, R Suratekar, ... Scientific reports 13 (1), 257, 2023 | 3 | 2023 |
| Identification and characterization of immune checkpoint inhibitor–induced toxicities from electronic health records using natural language processing H Barman, S Venkateswaran, AD Santo, U Yoo, E Silvert, K Rao, ... JCO Clinical Cancer Informatics 8, e2300151, 2024 | 1 | 2024 |
| Retrospective study of propionic acidemia using natural language processing in Mayo Clinic electronic health record data H Barman, V Sikirica, K Carlson, E Silvert, KB Carlson, S Boyer, R Glaser, ... Molecular genetics and metabolism 140 (3), 107695, 2023 | 1 | 2023 |
| Real-time analysis of a mass vaccination effort via an Artificial Intelligence platform confirms the safety of FDA-authorized COVID-19 vaccines R McMurry, PJ Lenehan, S Awasthi, E Silvert, A Puranik, C Pawlowski, ... | 1 | 2021 |
